TCR 2 Inc

Metabomed is a biotechnology company based in Cambridge, MA, specializing in drug discovery and development. With a focus on innovative approaches and cutting-edge technologies, Metabomed aims to address unmet medical needs and advance novel therapies for various diseases. Generated from their business information

Nanobiotix Corp is a biotechnology company based in Cambridge, MA that specializes in the development of innovative cancer therapies. They have recently achieved a significant $20 million development milestone payment for their ongoing global Phase 3 Head and Neck Cancer Study, and have also raised $55 million through a capital increase. With a strong focus on research and development, Nanobiotix is dedicated to advancing their science pipeline and collaborating with partners to bring effective treatments to patients. Through their cutting-edge technology, Nanobiotix aims to revolutionize cancer treatment by leveraging nanomedicine to enhance the efficacy of radiation therapy. Their preliminary results from Phase 1 trials in pancreatic cancer and head and neck cancer have shown promising outcomes, further highlighting their commitment to improving patient outcomes. With a dedicated team of leaders, a scientific advisory board, and a strong presence in the media and investor community, Nanobiotix is poised to make a significant impact in the field of oncology.Generated from the website

Foundation Medicine, Inc., based in Cambridge, MA, is transforming cancer care through comprehensive genomic profiling, offering a range of tests that provide deep insights into the genomic mutations driving cancer. Their portfolio includes tests like FoundationOne CDx and FoundationOne Liquid CDx, aimed at matching patients with targeted therapies, immunotherapies, and clinical trial options. With a commitment to advancing precision medicine, Foundation Medicine supports healthcare providers, researchers, and biopharmaceutical partners through its extensive database and expertise in genomic data interpretation. Their services not only enhance treatment strategies for advanced cancer patients but also aid in the development of new therapies and improve overall patient care. Generated from the website